REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 66 filers reported holding REGULUS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $46,139 | +11180.9% | 25,848 | +18102.8% | 0.00% | – |
Q1 2024 | $409 | +127.2% | 142 | +1.4% | 0.00% | – |
Q4 2023 | $180 | +2.9% | 140 | +9.4% | 0.00% | – |
Q3 2023 | $175 | -6.4% | 128 | +0.8% | 0.00% | – |
Q2 2023 | $187 | +107.8% | 127 | +19.8% | 0.00% | – |
Q1 2023 | $90 | -28.6% | 106 | +15.2% | 0.00% | – |
Q4 2022 | $126 | – | 92 | +2.2% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 90 | -87.5% | 0.00% | – |
Q2 2022 | $1,000 | – | 718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,111,049 | $1,522,137 | 0.47% |
Sarissa Capital Management LP | 185,183 | $253,701 | 0.03% |
FEDERATED HERMES, INC. | 3,875,578 | $5,348,298 | 0.01% |
Virtu Financial LLC | 25,921 | $36 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 40,260 | $55,156 | 0.00% |
GRIMES & COMPANY, INC. | 10,547 | $14,449 | 0.00% |
NORTHERN TRUST CORP | 17,978 | $24,630 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 408 | $558 | 0.00% |
Community Bank, N.A. | 690 | $938 | 0.00% |